Details of the Drug

General Information of Drug (ID: DM2T41T)

• Drug Name: MDR-103

Indication

Disease Entry	ICD 11	Status	REF
Kidney transplant rejection	NE84	Phase 2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DKB8X2

References

• [1] ClinicalTrials.gov (NCT03606746) Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants. U.S. National Institutes of Health.